To date, we have invested over €20 million in more than 115 research and clinical projects. Here you can learn more about our current and previous funded projects and researchers.
The pace of research has never been so rapid. We aim to provide you the most up to date news on the advances as they happen.
PPI is the working partnership between patients, clinicians, scientists, industry and regulators to advance research and access to therapies.
Understand the different stages that are needed to develop a therapy and the many exciting approaches underway.
Target 5000 provides clinical and genotyping services for people living in Ireland with an inherited retinal degeneration.
We are committed to driving the development of therapies and cures, which are accessible to all patients affected by sight loss and the wide spectrum of retinal degenerative disease.
